INSIGHTS ON QUALITY ASSURANCE

• Why Cloud Migration Is The Key To Business Agility

  Discover how transitioning to cloud-native architectures drives business agility in biopharma, reducing infrastructure costs, minimizing downtime, and accelerating time to market for novel therapies.

• Step Into The Future Of Chromatography Automation

  As downstream processing grows more connected and complex, chromatography remains a key automation challenge. See how greater flexibility and stronger control are shaping more practical workflows.

• Robust Database Characterizes And Optimizes Product Development

  Integrating material characterization data with process parameters accelerates drug development, reduces empirical testing, and strengthens regulatory compliance.

• QMSR Is Done. Now What?

  Align with FDA QMSR requirements by integrating ISO 13485 standards, moving quality management upstream, and tracking process health metrics to ensure continuous regulatory compliance.

• Optimizing Antibody Variant Capture: Strategies To Combat Aggregation, Impurities, And Low Yields

  2/26/2026

  Explore how process conditions affect bispecific antibody stability and impurity formation, as well as practical strategies to minimize aggregation and remove product‑related variants.

• Visibility For BioPharma Operation: From Data Insights To Better Outcomes

  10/16/2026

  Handoffs between development, scheduling, execution, and quality are where speed is won or lost. The open question is how much context survives each one.

• Cambrex Scientist Spotlight: Kelly McGuill

  1/29/2025

  McGuill is dedicated to inspiring the next generation of scientists. Her commitment to quality ensures that clients stay compliant and focused on advancing to the next phase of their projects.

• Site Expansion Without Added Compliance Risk

  3/31/2026

  Multi-site expansion doesn’t require rebuilding maintenance and calibration programs from scratch. What matters is standardized work, reliable data, and clear oversight that holds up in every facility.

• Preparing Global Parenteral Sites For Annex 1 Compliance

  9/1/2026

  Modern sterile manufacturing requires proactive quality risk management. Robust contamination control across facilities, processes, and supply chains supports compliance and patient safety.